logo
Residents welcome new hospital in Southeast D.C.: ‘We need this'

Residents welcome new hospital in Southeast D.C.: ‘We need this'

Washington Post15-04-2025
The District's newest hospital, Cedar Hill Regional Medical Center GW Health in Congress Heights, officially opened to patients at 12:01 a.m. Tuesday. Minutes later the first patient walked in. Then the first ambulance pulled up.
And by midafternoon, 79 patients had visited the emergency department, a hospital spokeswoman said.
A decade after Mayor Muriel E. Bowser promised Southeast Washington residents a hospital, and three years after construction began, the first new hospital in the District in a generation has begun the hard work of caring for a long-underserved community with complex medical needs.
'It's a long time coming on this end of town,' said Muriel Langford, 73, a retired Southeast resident, standing outside the main entrance. 'We need this … the key thing is having this on this end of [wards] 7 and 8 so I'm appreciative that this [hospital] is here.'
The city funded nearly all of the $434 million construction costs and turned operations over to Universal Health Services, the same Fortune 300 company that runs George Washington University Hospital, banking on the reputation of the academic medical center in Foggy Bottom.
'When people say we want in Ward 8, we want the same things as people in Ward 2, 3, 4, 5, 6, 7 — we want the same things. And so we are proud of our partnership with the GW Health,' Bowser said last week at the ribbon-cutting.
Cedar Hill is replacing the only other hospital east of the Anacostia River, United Medical Center, and expanding the care available, giving mothers a labor and delivery unit close to home for the first time in eight years. A trauma center at Cedar Hill, the first in Southeast in at least 30 years, will eventually treat all but the most severe injuries.
An adult emergency department and a pediatric emergency department run by Children's National Hospital were up and running Tuesday, and staff were in place to open about three-quarters of the 136 beds, hospital spokeswoman Susan LaRosa has said.
People often turn to hospitals when they have no other option for care, but city officials have said Cedar Hill could connect patients with trusted community clinics, including Unity Health Care, Community of Hope and Whitman-Walker. The path to turning around stark health disparities in D.C. runs through the primary care doctors and nurses who help residents prevent and manage chronic conditions, public health experts say.
The average life expectancy of the poor, majority African American residents in wards east of the Anacostia River lags behind the rest of the city. And, Black District residents citywide died of cancer, heart disease and diabetes at much higher rates than White and Hispanic residents, according to D.C. health department data from 2019 to 2023.
Aneathia Brown, 25, who brought her 4-year-old daughter Angel to Cedar Hill on Tuesday, said she has gotten care all over the city, but hopes she can turn to Cedar Hill for most of her family's needs going forward.
Brown recently had surgery for an ectopic pregnancy at MedStar Georgetown University Hospital and before that went to MedStar Washington Hospital Center in Northwest Washington for prenatal care. Cedar Hill would significantly cut the travel time for treatment from her home in Southeast near Prince George's County.
'I'm hoping this one is kind of like Georgetown,' she said.
Cedar Hill also will offer specialty care in Southeast, including many services that residents previously had to travel across the city to find. Hospital officials declined to provide a list of what specialty services were available on Day 1, but noted that beds and services will expand based on the needs of patients including cardiology, neurology and cancer care.
When fully operational in several weeks, the hospital will have 600 workers, and as of Tuesday about 300 people were hired, LaRosa said. That includes 84 residents of Wards 7 and 8. At least half of Cedar Hill employees must live in D.C. with exceptions for hard-to-fill positions, according to contract documents.
Langford, who visited the hospital Tuesday, is helping her nephew reintegrate into the community after being incarcerated and wanted to know the status of his job application to work in housekeeping.
A survivor of breast and stomach cancer, Langford uses senior transport services like MetroAccess to see her primary and specialty care doctors at MedStar Washington Hospital Center and doesn't anticipate switching providers to go to Cedar Hill.
However, in case of an emergency, she said it's comforting to know a full-service hospital is minutes from her home.
'This is where they should bring me,' she said. 'Right here.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Self-Management Asthma App Boosts Symptom Control in Adults
Self-Management Asthma App Boosts Symptom Control in Adults

Medscape

time5 minutes ago

  • Medscape

Self-Management Asthma App Boosts Symptom Control in Adults

TOPLINE: In adults with asthma, a digital asthma self-management (DASM) program improved symptom control compared with usual care, although its effectiveness varied by race, with weaker results observed among African American participants. METHODOLOGY: Researchers conducted a randomized trial to evaluate the impact of a DASM program on symptom control among adults with asthma. A total of 899 participants (mean age, 36.6 years; 71.1% women; approximately 61.3% with uncontrolled asthma) were recruited via email between October 2020 and November 2021 to receive either the DASM program (n = 450) or usual care (n = 449). All the enrolled participants installed a custom smartphone app and utilized wearable devices during the trial. The DASM group received a full-featured self-management version with symptom tracking and alerts, whereas the usual care group received a limited version with only the asthma control test and collection of patient-reported outcomes. The primary outcomes included the 12-month change from baseline in asthma control test scores (scores ≤ 19 indicated uncontrolled asthma), and secondary outcomes included participants' counts of symptom logs and patient-reported outcomes. TAKEAWAY: Among participants with uncontrolled asthma, the DASM intervention improved mean asthma control test scores by 4.6 points at 12 months compared with a 1.8-point improvement with usual care (adjusted difference, 2.8 points; P < .001). The treatment effect varied by race, with between-group differences in asthma control test scores showing improvements of 1.0 point (P = .26) in African American participants and 3.3 points (P < .001) in non-African American participants. Symptom logging rates were comparable across insurance and ethnicity subgroups, with no significant differences observed. However, African American participants logged symptoms less frequently than non-African American participants. Patient-reported outcomes — self-reported medication adherence, readiness to change self-management behaviors, confidence in the ability to manage one's health, and asthma-related work productivity impairment — also favored the DASM intervention over usual care (P ≤ .001 for all). IN PRACTICE: 'Findings reveal an opportunity to adapt the DASM program for more consistent effects throughout diverse populations. Future research is needed — quantitative and qualitative — to elucidate causes of differences in outcomes,' the authors wrote. SOURCE: The study was led by Jordan Silberman, MD, PhD, Office of Medical Policy and Technology Assessment, Elevance Health, Palo Alto, California. It was published online on July 17, 2025, in JAMA Network Open. LIMITATIONS: The study was limited by the requirement for iPhone ownership, exclusion of uninsured participants, lack of blinding, and potential for biased missingness despite robust sensitivity analyses. DISCLOSURES: This study was funded by Elevance Health, Inc. (formerly Anthem Inc.), with support from Apple Inc. Three authors declared receiving financial support from Apple or grants from Elevance Health. One author reported receiving stock from Elevance Health. Few other authors reported receiving financial aid from the University of California and pharmaceutical companies, including Pfizer, AstraZeneca, and Eli Lilly and Company. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Using food stamps can help slow down brain decline as you age: study
Using food stamps can help slow down brain decline as you age: study

New York Post

time2 hours ago

  • New York Post

Using food stamps can help slow down brain decline as you age: study

The federally funded food stamp program is really delivering for brain health, a new study finds. Over 41 million people participated last year in the US Supplemental Nutrition Assistance Program (SNAP), which helps low-income families purchase nutritious food. We've long known that healthy foods — especially those rich in omega-3 fatty acids, antioxidants and vitamins — can support brain function, memory and cognitive performance. A nutritious diet can support brain function, protect against cognitive decline and potentially reduce the risk of neurodegenerative diseases. Kay Abrahams/ – Now, new research reports that older SNAP recipients have a better chance of staving off cognitive decline than their peers who do not partake in the program. 'Research has shown that food insecurity can negatively impact cognitive function, and this is one of the first long-term studies to show that food assistance programs can positively impact cognition,' said Maria C. Carrillo, chief science officer and medical affairs lead for the Alzheimer's Association. The study, out of the University of Georgia, tracked 1,100 people 50 and older who were enrolled in SNAP in 2010 and 1,200 older adults who were eligible for SNAP but did not participate. Researchers interviewed participants every two years between 2010 and 2020 to assess their memory and ability to plan and carry out tasks. Over 41 million people participated last year in the US Supplemental Nutrition Assistance Program (SNAP), which helps low-income families purchase nutritious food. They determined that SNAP participants had a 0.10% slower decline in overall cognitive function, affording them two to three additional years of good brain health in the 10-year study period. 'For someone starting at a healthy cognitive score, this slower decline could delay reaching the threshold for mild cognitive impairment by nearly a decade,' said Linlin Da, lead study author and a Ph.D. candidate in health services research at UGA. People with mild cognitive impairment face a significantly higher risk of developing dementia, a decline in memory, thinking, language, judgment and behavior that is so severe that it interferes with daily life. While all SNAP participants seemed to benefit brain-wise, Da's team noticed that white SNAP recipients exhibited even slower cognitive decline than black and Hispanic participants. The researchers are calling for further exploration into the racial and ethnic disparities in the relationship between SNAP and cognitive health. Their findings were presented Wednesday at the Alzheimer's Association International Conference in Toronto. The study results come weeks after President Trump's 'One Big Beautiful Bill' introduced steep cuts to SNAP, making it harder for people to qualify and decreasing benefits for eligible recipients. SNAP participants averaged about $187 in monthly benefits before the legislation was approved. The program — which dates back to 1939, during the Great Depression — cost about $100 billion in federal funding last year.

MedaSystems Strengthens Executive Team with Appointment of Anton White as Vice President of Growth
MedaSystems Strengthens Executive Team with Appointment of Anton White as Vice President of Growth

Business Wire

time3 hours ago

  • Business Wire

MedaSystems Strengthens Executive Team with Appointment of Anton White as Vice President of Growth

MENLO PARK, Calif.--(BUSINESS WIRE)--MedaSystems, the leading SaaS platform for Expanded Access (EA) and Investigator‑Initiated Studies (IIS), today announced that healthcare‑technology veteran Anton White has joined the company as Vice President of Growth. White will lead global go‑to‑market strategy and execution as MedaSystems scales to meet accelerating demand from biopharmaceutical partners worldwide. 'I'm thrilled to join MedaSystems and help transform the way BioPharma and physicians collaborate to provide compliant, compassionate access to investigational therapies." Share 'Anton brings a rare combination of deep life‑sciences expertise and a growth‑mindset leadership style that aligns perfectly with our culture,' said Brian Irwin, Chief Executive Officer of MedaSystems. 'His track record of building high‑performing, customer‑centric teams will be instrumental at this pivotal moment as we enter our next phase of rapid expansion.' White joins MedaSystems after more than two decades of success driving revenue and building award‑winning teams at Optum Life Sciences, Eli Lilly, Celgene, and OptumRx. At Optum, he oversaw national sales and strategic partnerships, delivering data, analytics, and clinical‑services solutions to top‑10 global pharma companies and emerging biotech companies. 'I'm thrilled to join MedaSystems and help transform the way BioPharma and physicians collaborate to provide compliant, compassionate access to investigational therapies,' said Anton White, Vice President of Growth, MedaSystems. 'Together we'll empower sponsors and investigators with software that streamlines regulatory processes and accelerates patient access to life‑changing treatments.' White holds an MBA in Pharmaceutical & Healthcare Marketing from Saint Joseph's University, a BA in Management and Spanish from Gettysburg College, and a Sales Team Management Strategies certificate from Columbia Business School Executive Education. About MedaSystems MedaSystems is the leading developer of secure, GxP‑compliant software for managing requests for experimental therapies—including Expanded Access, Post‑Trial Access, and Investigator‑Initiated Studies. By connecting physicians and pharmaceutical companies in a centralized, audit‑ready environment, MedaSystems reduces administrative burden, improves data quality, and helps patients worldwide gain timely access to investigational treatments.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store